ADS-ADEA 2016* , ,
Presentations this author is a contributor to:
Insulin initiation in primary care for patients with type 2 diabetes: 24 month follow-up of the Stepping Up trial (#108)
12:00 PM
Jo-Anne Manski-Nankervis
ADEA Oral Presentations - Innovations in Clinical Practice
Glycaemic variability in Type 1 diabetes patients is better with continuous subcutaneous insulin infusion (CSII) therapy than with multiple daily injection (MDI) treatment. (#87)
10:00 AM
Emma Scott
ADS President's Clinical Young Investigator Award
A Comparison of Glycaemic Control in Adults and Adolescents With Type 1 Diabetes When Using a Closed Loop Insulin Delivery System Overnight Versus Sensor-Augmented Pump With Low Glucose Suspend At Home: A Randomised Crossover Study (#159)
9:00 AM
Amin Sharifi
ADS Clinical Orals - Type 1 Diabetes